{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:27:11Z","timestamp":1787498831491,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.contraception.2025.110867","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T12:33:52Z","timestamp":1743251632000},"page":"110867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 \u2013 Breast, ovarian, uterine, and cervical cancer: Joint with the Society of Gynecologic Oncology"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-2105","authenticated-orcid":false,"given":"Pelin","family":"Batur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor Bimla","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.110867_bib1","unstructured":"Batur P, Brant A, McCourt C, Schwarz EB. Society of Family Planning Clinical Recommendation: contraceptive considerations for individuals with cancer and cancer survivors part 1 - key considerations for clinical care. Contraception n.d."},{"key":"10.1016\/j.contraception.2025.110867_bib2","unstructured":"Batur P, Brant A, McCourt C, Schwarz EB. Society of Family Planning Clinical Recommendation: contraceptive considerations for individuals with cancer and cancer survivors part 3 - skin, blood, gastrointestinal, liver, lung, central nervous system, and other cancers. Contraception n.d."},{"key":"10.1016\/j.contraception.2025.110867_bib3","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2025.110867_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case\u2013control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.contraception.2025.110867_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/GME.0000000000002136","article-title":"Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients","volume":"30","author":"Pederson","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2025.110867_bib6","first-page":"292","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet\u00a0Gynecol"},{"key":"10.1016\/j.contraception.2025.110867_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jama.2024.18575","article-title":"Breast cancer in users of levonorgestrel-releasing intrauterine systems","volume":"332","author":"M\u00f8rch","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2025.110867_bib8","first-page":"174","article-title":"Breast cancer recurrence risk after hormonal contraceptive use in survivors of reproductive age","volume":"258","author":"Ostroot","year":"2021","journal-title":"Eur\u00a0J\u00a0Obstet\u00a0Gynecol\u00a0Reprod\u00a0Biol"},{"key":"10.1016\/j.contraception.2025.110867_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2025.110867_bib10","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: a systematic review and meta-analysis","volume":"39","author":"Lambertini","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.contraception.2025.110867_bib11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.11634","article-title":"Childbearing and survival after breast carcinoma in young women","volume":"98","author":"Mueller","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.contraception.2025.110867_bib12","article-title":"ACOG Practice Bulletin No. 206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","year":"2019","journal-title":"Obstet\u00a0Gynecol"},{"key":"10.1016\/j.contraception.2025.110867_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.110867_bib14","first-page":"1034","article-title":"Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-based Review","volume":"112","author":"Chen","year":"2019","journal-title":"Fertil\u00a0Steril"},{"key":"10.1016\/j.contraception.2025.110867_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00404-020-05458-w","article-title":"Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review","volume":"301","author":"Huber","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2025.110867_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: a systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"JNCI: J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2025.110867_bib17","doi-asserted-by":"crossref","first-page":"k3609","DOI":"10.1136\/bmj.k3609","article-title":"Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study","volume":"362","author":"Iversen","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.110867_bib18","first-page":"927","article-title":"Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins","volume":"30","author":"Phung","year":"2021","journal-title":"Cancer Epidemiol\u00a0Biomark\u00a0Prev"},{"key":"10.1016\/j.contraception.2025.110867_bib19","first-page":"127","article-title":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study","volume":"149","author":"Jareid","year":"2018","journal-title":"Gynecol\u00a0Oncol"},{"key":"10.1016\/j.contraception.2025.110867_bib20","first-page":"418","article-title":"Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer","volume":"156","author":"D\u2019Alessandro","year":"2022","journal-title":"Int\u00a0J\u00a0Gynecol\u00a0Obstet"},{"key":"10.1016\/j.contraception.2025.110867_bib21","first-page":"791","article-title":"Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis","volume":"134","author":"Wheeler","year":"2019","journal-title":"Obstet\u00a0Gynecol"},{"key":"10.1016\/j.contraception.2025.110867_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case\u2013control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2025.110867_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ije\/dyh046","article-title":"Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65,000 sterilized women","volume":"33","author":"Kjaer","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.contraception.2025.110867_bib24","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1097\/AOG.0000000000003164","article-title":"ACOG Committee Opinion No. 774: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110867_bib25","first-page":"492","article-title":"Borderline ovarian tumors: guidelines from the French National College of Obstetricians and Gynecologists (CNGOF)","volume":"256","author":"Bourdel","year":"2021","journal-title":"Eur\u00a0J\u00a0Obstet\u00a0Gynecol\u00a0Reprod\u00a0Biol"},{"key":"10.1016\/j.contraception.2025.110867_bib26","first-page":"441","article-title":"Clinical practice guidelines for contraception by the French National College of Gynecologists and Obstetricians (CNGOF)","volume":"48","author":"Chabbert-Buffet","year":"2019","journal-title":"J\u00a0Gynecol\u00a0Obstet\u00a0Hum\u00a0Reprod"},{"key":"10.1016\/j.contraception.2025.110867_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/IGC.0000000000000304","article-title":"Clinical characteristics and survival of patients with an adult-type ovarian granulosa cell tumor: a 56-year single-center experience","volume":"25","author":"Bryk","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.contraception.2025.110867_bib28","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e36","article-title":"Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis","volume":"34","author":"Wei","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.contraception.2025.110867_bib29","unstructured":"National Comprehensive Cancer Network. (2023). Uterine Neoplasms, Version 1.2023. NCCN Clinical Practice Guidelines in Oncology. [Accessed March 29, 2025]."},{"key":"10.1016\/j.contraception.2025.110867_bib30","first-page":"774","article-title":"Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus Depo-Provera for prevention of endometrial cancer in women with lynch syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev\u00a0Res"},{"key":"10.1016\/j.contraception.2025.110867_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2009.03.022","article-title":"Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease","volume":"80","author":"Gaffield","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110867_bib32","first-page":"364","article-title":"Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?","volume":"147","author":"Dantas","year":"2017","journal-title":"Gynecol\u00a0Oncol"},{"key":"10.1016\/j.contraception.2025.110867_bib33","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1471-0528.13617","article-title":"Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review","volume":"123","author":"Braga","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2025.110867_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2021.10.018","article-title":"The relationship between hormonal contraception and cervical dysplasia\/cancer controlling for human papillomavirus infection: a systematic review","volume":"107","author":"Anastasiou","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110867_bib35","first-page":"769","article-title":"Contemporary hormonal contraception and cervical cancer in women of reproductive age","volume":"149","author":"Iversen","year":"2021","journal-title":"Int\u00a0J\u00a0Cancer"},{"key":"10.1016\/j.contraception.2025.110867_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.contraception.2025.110867_bib37","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.contraception.2025.110867_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2018.04.008","article-title":"Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer","volume":"98","author":"Averbach","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110867_bib39","first-page":"1796","article-title":"Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark","volume":"36","author":"Skorstengaard","year":"2021","journal-title":"Hum\u00a0Reprod"},{"key":"10.1016\/j.contraception.2025.110867_bib40","first-page":"1226","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet\u00a0Gynecol"},{"key":"10.1016\/j.contraception.2025.110867_bib41","first-page":"86","article-title":"Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study","volume":"165","author":"Serati","year":"2012","journal-title":"Eur\u00a0J\u00a0Obstet\u00a0Gynecol\u00a0Reprod\u00a0Biol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:13:03Z","timestamp":1762117983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"alternative-id":["S0010782425000587"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110867","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 \u2013 Breast, ovarian, uterine, and cervical cancer: Joint with the Society of Gynecologic Oncology","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110867"}}